ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

COMMIT Moving Into Implementation

July 15, 1988

In Brief: Willis Taylor New ACS President, Gerald Murphy President Elect, Robert Gadberry Bord Chairman

November 19, 1982

House Completes Committee Lineups

February 18, 1977

Phase III Kyprolis Trial Fails OS Primary Endpoint

August 29, 2014

American Association for Cancer Research Presents Awards at 2012 Annual Meeting

April 6, 2012

Medicare Will Cover Patient Care Costs For All Phases Of Cancer Treatment Trials.

September 1, 2000